POINT RICHMOND, Calif. and TOKYO, Sept. 25, 2013 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (NASDAQ: TSPT), and Shin Nippon Biomedical Laboratories, Ltd ("SNBL"), today announced that the companies have entered into an exclusive worldwide licensing agreement for a novel, rapidly......
More...







